hydralazine has been researched along with Deficiency of Glucose-6-Phosphate Dehydrogenase in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Padakanti, A | 1 |
| Shenoy, A | 1 |
| Kamath, A | 1 |
| Chakrapani, M | 1 |
| EVANS, DA | 1 |
2 other studies available for hydralazine and Deficiency of Glucose-6-Phosphate Dehydrogenase
| Article | Year |
|---|---|
Drug-induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition.
Topics: Cardiovascular Agents; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Huma | 2019 |
CONJOINT CLINIC ON DRUGS AND GENES.
Topics: Acetates; Aminosalicylic Acid; Aminosalicylic Acids; Coenzyme A; Diabetes Mellitus; Genetics, Medica | 1965 |